From Idea to Patient

In Research, we identify new disease targets and establish and confirm an understanding of the mechanism of action for new drug candidates. Researching new treatments requires deep insight into the disease and into the unmet medical needs of patients. Researchers work to understand the underlying disease biologyand identify new targets in the brain. New substances are then selected based on efficacy and are tested for safety and tolerability, before being advanced for drug development.

In Drug Development, we conduct clinical studies globally to establish evidence for new drug candidates, we engage healthcare specialists in scientific discussions to enhance the understanding of our clinical results, and we work to develop safe, reliable and efficient manufacturing processes. Safeguarding the rights, safety and wellbeing of study participants is of the greatest importance.

We conduct ongoing monitoring to evaluate the safety, quality and effectiveness of our products and we continuously inform regulatory authorities about our activities and findings. The reporting of potential adverse drug reactions by healthcare professionals and patients is very important to continuously evaluate the benefits and risks of our products allowing us to take proactive action aswarranted.

The production process has three major stages: Chemical Production where the Active Pharmaceutical Ingredient (API) is made; Pharmaceutical Bulk Production where the product is produced; and the Finished Goods Production where the packs are assembled. We strive to create the best supply chain in the pharmaceutical industry through continuous improvement of reliability, quality and cost. Every year, more than 100 million finished goods are sent to distributors, wholesalers and hospitals through close collaboration with our sales affiliates globally.

Our products are registered globally in more than 100 countries. We produce and conduct scientific and events to educate HCPs about the effective use of our products.